Abstract
Autosomal recessive spinal muscular atrophy (SMA) is a common motor neuron disease caused by absence or mutation in the survival motor neuron (SMN1) gene. SNM1 and a nearly identical copy, SMN2, encode identical proteins, but SMN2 only produces a little full length protein due to alternative splicing. The level of functional SMN protein and the number of SMN2 genes correlate with the clinical phenotype ranging from severe to very mild. Here, we report on premature termination mutations in SMN1 exon 3 (425del5 and W102X) which induce skipping of the mutated exon. The novel nonsense mutation W102X was detected in two patients with a relatively mild phenotype who had only two copies of the SMN2 gene, a number that has previously been found associated with the severe form of SMA. We show that the shortened transcripts are translated into predicted in frame protein isoforms. Aminoglycoside treatment suppressed the nonsense mutation in cultured cells and abolished exon skipping. Fibroblasts from both patients show a high number of nuclear structures containing SMN protein (gems). These findings suggest that the protein isoform lacking the exon 3 encoded region contributes to the formation of the nuclear protein complex which may account for the milder clinical phenotype.
Similar content being viewed by others
Article PDF
References
Munsat TL, Davies KE: . Meeting Report. International SMA Consortium meeting. Neuromusc Disord 1992 2: 423–428.
Lefebvre S, Bürglen L, Reboullet S et al:. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995 80: 155–165.
Lorson CL, Hahnen E, Androphy EJ, Wirth B: . A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 1999 96: 6307–6311.
Monani UR, Lorson CL, Parsons DW et al:. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 1999 8: 1177–1183.
Gennarelli M, Lucarelli M, Capon M et al:. Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun 1995 213: 342–348.
Lorson CL, Androphy EJ: . An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 2000 9: 259–265.
Lefebvre S, Burlet P, Liu Q et al:. Correlation between severity and SMN protein level in spinal muscular atrophy. Nature Genet 1997 16: 265–269.
Vitali T, Sossi V, Tiziano F et al:. Detection of the survival motor neuron (SMN) genes by FISH: further evidence for a role for SMN2 in the modulation of disease severity in SMA patients. Hum Mol Genet 1999 8: 2525–2532.
Coovert DD, Le TT, McAndrew PE et al:. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 1997 6: 1205–1214.
Taylor JE, Thomas NH, Lewis CM et al:. Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy. Eur J Hum Genet 1998 6: 467–474.
Campbell L, Potter A, Ignatius J, Dubowitz V, Davies KE: . Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet 1997 61: 40–50.
Wirth B: . An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutation 2000 15: 228–237.
Parsons DW, McAndrew PE, Iannaccone ST, Mendell JR, Burghes AHM, Prior TW: . Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. Am J Hum Genet 1998 63: 1712–1723.
Wirth B, Herz M, Wetter A et al:. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet 1999 64: 1340–1356.
Liu Q, Fischer U, Wang F, Dreyfuss G: . The spinal muscular atrophy disease gene product SMN, and its associated protein SIP1 are in a complex with spiceosomal snRNP proteins. Cell 1997 90: 1013–1021.
Liu Q, Dreyfuss G: . A novel nuclear structure containing the survival of motor neurons protein. EMBO J 1996 15: 3555–3565.
Pellizoni L, Kataoka N, Charroux B, Dreyfuss G: . A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 1998 95: 615–624.
Patrizi AL, Tiziano F, Zappata S, Donati MA, Neri G, Brahe C: . SMN protein analysis in fibroblast, anmiocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis. Eur J Hum Genet 1999 7: 301–309.
Charroux B, Pellizoni L, Perkinson RA, Shevchenko A, Mann M, Dreyfuss G: . Gemin3: A novel DEAD box protein that interacts with SMN, the Spinal muscular atrophy gene product, and is a component of gems. J Cell Biol 1999 147: 1181–1193.
Bühler D, Raker V, Lührmann R, Fischer U: . Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy. Hum Mol Genet 1999 8: 2351–2357.
Talbot K, Miguel-Aliaga I, Mohaghegh P, Ponting CP, Davies KE: . Characterization of a gene encoding survival motor neuron (SMN)-related protein, a consituent of the spliceosome complex. Hum Mol Genet 1998 7: 2149–2156.
Brahe C, Clermont O, Zappata S, Tiziano F, Melki J, Neri G: . Frameshift mutation in the survival motor neuron gene in a severe case of SMA type I. Hum Mol Genet 1996 5: 1971–1976.
Van der Steege G, Grootscholten PM, van der Vlies P et al:. PCR-based DNA test to confirm the clinical diagnosis of autosomal recessive spinal muscular atrophy (SMA). Lancet 1995 345: 985–986.
Howard M, Frizzell RA, Bedwell DM: . Aminoglycoside antibiotics restore CFTR function by overcoming premature stop muations. Nature Med 1996 2: 467–469.
Velasco E, Valero C, Valero A, Moreno F, Hernandez-Chico C: . Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet 1996 5: 257–263.
Valentine CR: . The association of nonsense codons with exon skipping. Mutation Res 1998 411: 87–117.
McAndrew PE, Parsons DW, Simard LR et al:. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNt and SMNc gene copy number. Am J Hum Genet 1997 60: 1411–1422.
Dubowitz V: . Chaos in the clasification of SMA: A possible resolution. Neuromusc Disord 1995 5: 3–5.
Clermont O, Burlet P, Cruaud C et al:. Mutation analysis of the SMN gene in undeleted SMA patients. Am J Hum Genet 1997 61: A329.
Mohaghegh P, Rodrigues NR, Owen N et al:. Analysis of mutations in the tudor domain of the survival motor neuron protein SMN. Eur J Hum Genet 1999 7: 519–525.
Hannus S, Bühler D, Romano M, Seraphin B, Fischer U: . The Schizosaccharomyces pombe protein Yab8p and a novel factor, Yip1p, share structural and functional similarity with the spinal muscular atrophy-associated proteins SMN and SIP1. Hum Mol Genet 2000 9: 663–674.
Barton-Davies ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL: . Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clinic Invest 1999 104: 375–381.
Acknowledgements
We thank the patients and the Italian Union for Muscular Dystrophies (UILDM) for their kind cooperation. We thank Dr G Dreyfuss for providing the 2B1 monoclonal antibody. The financial support of Telethon Italy (grant 828) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sossi, V., Giuli, A., Vitali, T. et al. Premature termination mutations in exon 3 of the SMN1 gene are associated with exon skipping and a relatively mild SMA phenotype. Eur J Hum Genet 9, 113–120 (2001). https://doi.org/10.1038/sj.ejhg.5200599
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejhg.5200599
Keywords
This article is cited by
-
Revealing diverse alternative splicing variants of the highly homologous SMN1 and SMN2 genes by targeted long-read sequencing
Molecular Genetics and Genomics (2022)
-
A New Series of Small Molecular Weight Compounds Induce Read Through of All Three Types of Nonsense Mutations in the ATM Gene
Molecular Therapy (2013)
-
Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study
European Journal of Human Genetics (2013)
-
Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene
Human Genetics (2009)
-
A novel mutation at the N-terminal of SMN Tudor domain inhibits its interaction with target proteins
Journal of Neurology (2007)